|
cont. from
Other Considerations
Anorexia poses a number of potential problems for the woman who is pregnant
or wishes to become pregnant:
- Difficulty getting pregnant/carrying a pregnancy to term because of
higher rates of infertility and spontaneous abortion
- Increased risk of low birth weight babies and birth defects
- Malnourishment (particularly calcium deficiency) as the fetus grows
- Increased risk of medical complications
- Increased risk of relapse being triggered from the stress of pregnancy
and/or parenthood
Medical complications associated with anorexia include:
- Irregular heartbeat and heart attack
- Anemia, often related to lack of vitamin B12
- Low potassium, calcium, magnesium, and phosphate levels (particularly
with binge-purge types)
- Increased cholesterol
- Hormonal changes (can lead to absence of menstrual periods, infertility,
bone loss, and stunted growth)
- Osteoporosis
- Seizures and/or numbness in hands and feet
- Disorganized thinking
- Death (suicide is responsible for 50% of fatalities associated with
anorexia)
The outlook for individuals with anorexia is variable, with recovery taking
between 4 and 7 years. There is also a high chance of disease recurrence even
after recovery. Long-term studies show that 50% to 70% of people recover from
anorexia nervosa; however, 25% do not fully recover. Many, even after they are
considered "cured," continue to exhibit traits of anorexia such as remaining
very thin and striving for perfection.
Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation
in anorexia nervosa. Int J Eating Disord. 1994;15:251-255.
Biederman J, Herzog DB, Rivinus TM, et al. Amitriptyline in the treatment of
anorexia nervosa: a double-blind, placebo-controlled study. J Clin
Psychopharmacol. 1985;5(1):10-16.
Blumenthal M, Goldberg A, Brinkman J, ed. Herbal Medicine: Expanded
Commission E Monographs. Newton, MA: Integrative Medicine Communications and
American Botanical Council; 2000.
Crisp AH, Lacey JH, Crutchfield M. Clomipramine and 'drive' in people with
anorexia nervosa: an inpatient study. Br J Psychiatry. 1987;150:355-358.
Field T. Massage therapy effects. Am Psychol. 1998;53:1270-1281.
Gordon C, Grace E, Emans SJ, Goodman E, Crawford MH, Leboff MS. Changes in
bone turnover markers and menstrual function after short-term oral DHEA in young
women with anorexia nervosa. J Bone Miner Res. 1999;14:136-145.
Gross HA, Ebert MH, Faden VB, Goldberg SC, Nee LE, Kaye WH. A double-blind
controlled trial of lithium carbonate primary anorexia nervosa. J Clin
Psychopharmacol. 1981;1(6);376-381.
Halmi KA, Eckert E, LaDu TJ, Cohen J. Anorexia nervosa. Treatment efficacy of
Cyproheptadine and amitriptyline. Arch Gen Psychiatry. 1986;43(2):177-181.
Holman RT, Adams CE, Nelson RA, et al. Patients with anorexia nervosa
demonstrate deficiencies of selected essential fatty acids, compensatory changes
in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr
1995;125:901-907.
Humphries L, Vivian B, Stuart M, McClain CJ. Zinc deficiency and eating
disorders. J Clin Psychiatry. 1989;50:456-459.
Kennedy SH. Melatonin disturbances in anorexia nervosa and bulimia nervosa.
Int J Eating Disord. 1994;16:257-265.
Kleifield EI, Wagner S, Halmi KA. Cognitive-behavioral treatment of anorexia
nervosa. Psychiatric Clin N Am. 1996;19:715-737.
McClain CJ, Stuart M, Vivian B, et al. Zinc status before and after zinc
supplementation of eating disorder patients. J Am Col Nutr. 1992;11:694-700.
McNulty. Prevalence and contributing factors of eating disorder behaviors in
active duty Navy men. Mil Med. 1997;162(11):753-758.
Miller LG, Murray WJ, eds. Herbal Medicinals: A Clinician's Guide. New York,
NY: Pharmaceutical Products Press; 1998.
Moyano D, Sierra C, Brandi N, et al. Antioxidant status in anorexia nervosa.
Int J Eating Disord. 1999;25:99-103.
Pop-Jordanova N. Psychological characteristics and biofeedback mitigation in
preadolescents with eating disorders. Ped Int. 2000;42:76-81.
Rock CL, Vasantharajan S. Vitamin status of eating disorder patients:
Relationship to clinical indices and effect of treatment. Int J Eating Disord.
1995;18:257-262.
Safai-Kutti S. Oral zinc supplementation in anorexia nervosa. Acta Psychiatr
Scand Suppl. 1990;361(82):14-17.
Shay NF, Manigan HF. Neurobiology of zinc-influenced eating behavior. J Nutr.
2000;130:1493S-1499S.
Vandereycken W, Pierloot R. Pimozide combined with behavior therapy in the
short-term treatment of anorexia nervosa. A double-blind placebo-controlled
cross-over study. Acta Psychiatr Scand. 1982;66(6):445-450.
Wiseman CV, Harris WA, Halmi KA. Eating disorders. Medical Clin N Am.
1998;82:145-159.
Wolfe BE, Metzger ED, Jimerson DC. Research update on serotonin function in
bulimia nervosa and anorexia nervosa. Psychopharmacol Bull. 1997;33:345-354.
Young D. The use of hypnotherapy in the treatment of eating disorders.
Contemporary Hypnosis. 1995;12:148-153.
next:
How Anorexia Can Damage the Body
. section table of contents
top .
pages 1 2
3 4
5 6 7
.
send to friend .
eating disorders site
map
Reviewed: 03/2006
|